Triple

Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).

Phrase: ERBB2 | Statement: [Herceptin, antibodyTarget, ERBB2]

Target entity: ERBB2
Context triple: [Herceptin, antibodyTarget, ERBB2]

• A. EGF
  EGF is the ICAO airline designator used to identify American Eagle Airlines in aviation operations and communications.
• B. CD38
  CD38 is a cell surface glycoprotein with ectoenzyme and receptor functions, highly expressed on plasma cells and targeted in therapies for multiple myeloma and other hematologic malignancies.
• C. TARDBP
  TARDBP is a gene encoding the TDP-43 protein, a DNA/RNA-binding protein whose abnormal aggregation is a key pathological feature in amyotrophic lateral sclerosis and related neurodegenerative diseases.
• D. AACR2
  AACR2 (Anglo-American Cataloguing Rules, Second Edition) is a widely used library cataloging standard that provides rules for describing and accessing library materials in online and card catalogs.
• E. Herceptin
  Herceptin is a targeted monoclonal antibody drug used primarily to treat HER2-positive breast cancer by blocking the HER2 receptor on cancer cells.
• F. None of above. chosen
• G. Unsure - the case is ambiguous/there is not enough information to decide.

Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"

Entity: ERBB2
Triple: [Herceptin, antibodyTarget, ERBB2]

ERBB2, also known as HER2, is a receptor tyrosine kinase frequently overexpressed in certain breast and other cancers and serves as a key therapeutic target.

Target entity: ERBB2
Target entity description: ERBB2, also known as HER2, is a receptor tyrosine kinase frequently overexpressed in certain breast and other cancers and serves as a key therapeutic target.

• A. EGF
  EGF is the ICAO airline designator used to identify American Eagle Airlines in aviation operations and communications.
• B. ERK
  ERK is the abbreviation for the Evangelical Reformed Church, a Protestant regional church within the Reformed tradition.
• C. CD38
  CD38 is a cell surface glycoprotein with ectoenzyme and receptor functions, highly expressed on plasma cells and targeted in therapies for multiple myeloma and other hematologic malignancies.
• D. TARDBP
  TARDBP is a gene encoding the TDP-43 protein, a DNA/RNA-binding protein whose abnormal aggregation is a key pathological feature in amyotrophic lateral sclerosis and related neurodegenerative diseases.
• E. AACR2
  AACR2 (Anglo-American Cataloguing Rules, Second Edition) is a widely used library cataloging standard that provides rules for describing and accessing library materials in online and card catalogs.
• F. None of above. chosen

Target predicate: antibodyTarget
Context triple: [Herceptin, antibodyTarget, ERBB2]

• A. antibodyType
  Indicates the specific class or subtype of an antibody involved in the described relationship or context.
• B. antigen chosen
  Indicates that one entity functions as an antigen in relation to another, typically provoking or being recognized by an immune response.
• C. hasMolecularTarget
  Indicates that one entity (such as a drug or compound) is directed toward, binds to, or specifically interacts with a particular molecular target (such as a protein, receptor, or gene).
• D. hasTargetDisease
  Indicates that an entity (such as a treatment, study, or intervention) is directed toward, intended to affect, or primarily concerned with a specified disease.
• E. hasProteinBinding
  Indicates that one entity is capable of physically binding to or interacting specifically with a protein.
• F. None of above.